The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population

Antonio Capalbo; Francesca Sagnella; Rosanna Apa; A. M. Fulghesu; Antonio Lanzone; Andrea Morciano; A. Farcomeni; M. F. Gangale; Francesca Moro; Daniela Martinez; A. Ciardulli; C. Palla; M. L. Uras; F. Spettu; A. Cappai; C. Carcassi; Geraldina Neri; Francesco Danilo Tiziano

doi:10.1111/j.1365-2265.2012.04372.x

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population

Antonio Capalbo, Francesca Sagnella, Rosanna Apa, A. M. Fulghesu, Antonio Lanzone, Andrea Morciano, A. Farcomeni, M. F. Gangale, Francesca Moro, Daniela Martinez, A. Ciardulli, C. Palla, M. L. Uras, F. Spettu, A. Cappai, C. Carcassi, Geraldina Neri, Francesco Danilo Tiziano

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

33 Citazioni (Scopus)

Abstract

Polycystic ovary syndrome (PCOS) is a frequent condition, affecting about 15% of women of reproductive age. Because of its familial occurrence, a multifactorial model of susceptibility, including both genetic and environmental factors, has been proposed. However, the identification of genetic factors has been elusive.

Lingua originale	English
pagine (da-a)	113-119
Numero di pagine	7
Rivista	Clinical Endocrinology
Volume	77
DOI	https://doi.org/10.1111/j.1365-2265.2012.04372.x
Stato di pubblicazione	Pubblicato - 2012

Keywords

polimorfismi

Accesso al documento

10.1111/j.1365-2265.2012.04372.x

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Capalbo, A., Sagnella, F., Apa, R., Fulghesu, A. M., Lanzone, A., Morciano, A., Farcomeni, A., Gangale, M. F., Moro, F., Martinez, D., Ciardulli, A., Palla, C., Uras, M. L., Spettu, F., Cappai, A., Carcassi, C., Neri, G., & Tiziano, F. D. (2012). The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population. Clinical Endocrinology, 77, 113-119. https://doi.org/10.1111/j.1365-2265.2012.04372.x

@article{d5dfa529cbba4c65be219f8ce83612cb,

title = "The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population",

abstract = "Polycystic ovary syndrome (PCOS) is a frequent condition, affecting about 15% of women of reproductive age. Because of its familial occurrence, a multifactorial model of susceptibility, including both genetic and environmental factors, has been proposed. However, the identification of genetic factors has been elusive.",

keywords = "polimorfismi, polimorfismi",

author = "Antonio Capalbo and Francesca Sagnella and Rosanna Apa and Fulghesu, {A. M.} and Antonio Lanzone and Andrea Morciano and A. Farcomeni and Gangale, {M. F.} and Francesca Moro and Daniela Martinez and A. Ciardulli and C. Palla and Uras, {M. L.} and F. Spettu and A. Cappai and C. Carcassi and Geraldina Neri and Tiziano, {Francesco Danilo}",

year = "2012",

doi = "10.1111/j.1365-2265.2012.04372.x",

language = "English",

volume = "77",

pages = "113--119",

journal = "Clinical Endocrinology",

issn = "0300-0664",

publisher = "[Oxford]: [Blackwell Science].",

}

Capalbo, A, Sagnella, F, Apa, R, Fulghesu, AM, Lanzone, A, Morciano, A, Farcomeni, A, Gangale, MF, Moro, F, Martinez, D, Ciardulli, A, Palla, C, Uras, ML, Spettu, F, Cappai, A, Carcassi, C, Neri, G & Tiziano, FD 2012, 'The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population', Clinical Endocrinology, vol. 77, pagg. 113-119. https://doi.org/10.1111/j.1365-2265.2012.04372.x

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population. / Capalbo, Antonio; Sagnella, Francesca; Apa, Rosanna et al.

In: Clinical Endocrinology, Vol. 77, 2012, pag. 113-119.

Risultato della ricerca: Contributo in rivista › Articolo in rivista › peer review

TY - JOUR

T1 - The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population

AU - Capalbo, Antonio

AU - Sagnella, Francesca

AU - Apa, Rosanna

AU - Fulghesu, A. M.

AU - Lanzone, Antonio

AU - Morciano, Andrea

AU - Farcomeni, A.

AU - Gangale, M. F.

AU - Moro, Francesca

AU - Martinez, Daniela

AU - Ciardulli, A.

AU - Palla, C.

AU - Uras, M. L.

AU - Spettu, F.

AU - Cappai, A.

AU - Carcassi, C.

AU - Neri, Geraldina

AU - Tiziano, Francesco Danilo

PY - 2012

Y1 - 2012

N2 - Polycystic ovary syndrome (PCOS) is a frequent condition, affecting about 15% of women of reproductive age. Because of its familial occurrence, a multifactorial model of susceptibility, including both genetic and environmental factors, has been proposed. However, the identification of genetic factors has been elusive.

AB - Polycystic ovary syndrome (PCOS) is a frequent condition, affecting about 15% of women of reproductive age. Because of its familial occurrence, a multifactorial model of susceptibility, including both genetic and environmental factors, has been proposed. However, the identification of genetic factors has been elusive.

KW - polimorfismi

UR - http://hdl.handle.net/10807/13093

U2 - 10.1111/j.1365-2265.2012.04372.x

DO - 10.1111/j.1365-2265.2012.04372.x

M3 - Article

VL - 77

SP - 113

EP - 119

JO - Clinical Endocrinology

JF - Clinical Endocrinology

SN - 0300-0664

ER -

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian population

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo